Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 18.1 CNY -4.99% Market Closed
Market Cap: 20.2B CNY
Have any thoughts about
Shenzhen Kangtai Biological Products Co Ltd?
Write Note

Operating Margin
Shenzhen Kangtai Biological Products Co Ltd

18.2%
Current
20%
Average
-7.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.2%
=
Operating Profit
537.2m
/
Revenue
2.9B

Operating Margin Across Competitors

Country CN
Market Cap 20.2B CNY
Operating Margin
18%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 312.7B USD
Operating Margin
28%
Country US
Market Cap 158.3B USD
Operating Margin
19%
Country US
Market Cap 115.9B USD
Operating Margin
40%
Country US
Market Cap 112.4B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 133.6B AUD
Operating Margin
26%
Country US
Market Cap 82.6B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 34.5B EUR
Operating Margin
-22%
No Stocks Found

Shenzhen Kangtai Biological Products Co Ltd
Glance View

Market Cap
20.2B CNY
Industry
Biotechnology

Shenzhen Kangtai Biological Products Co., Ltd. engages in the manufacture, sale, and research and development of human vaccines. The company is headquartered in Shenzhen, Guangdong and currently employs 2,445 full-time employees. The company went IPO on 2017-02-07. is a China-based company and mainly engaged in research and development, manufacture and sale of vaccine. The main products of the company are recombinant hepatitis B virus, haemophilus influenzae type b combined vaccine, measles rubella combined attenuated live vaccine, non-cell Bai Bai Po haemophilus influenzae combined vaccine and other products. The firm operates its businesses primary in domestic market.

Intrinsic Value
22.35 CNY
Undervaluation 19%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.2%
=
Operating Profit
537.2m
/
Revenue
2.9B
What is the Operating Margin of Shenzhen Kangtai Biological Products Co Ltd?

Based on Shenzhen Kangtai Biological Products Co Ltd's most recent financial statements, the company has Operating Margin of 18.2%.